Intra and Postoperative Outcomes With 3 Injectors

NCT ID: NCT02466256

Last Updated: 2015-06-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-12-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized clinical trial compares subjective performance during Intraocular lens (IOL) implantation, as well as incision enlargement and anterior segment morphology on OCT when IOL implantation was performed during microcoaxial phacoemulsification through a 2.2mm incision using one of three injectors :

Manual screw type (Monarch III), Manual plunger type (Royale) and motorised injector (Autosert). Further, the investigators also looked at incision integrity by comparing ingress of trypan blue from the ocular surface into the anterior chamber.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this randomized, clinical trial, three types of injectors were compared :

1. Manual, screw type injector (Monarch III)
2. Manual, plunger type injector (Royale, ASICO)
3. Motorized injector (Autosert, Alcon)

Having performed a phacoemulsification through 2.2mm incision, IOL implantation was performed using a D cartridge and one of three injectors which was decided in a randomized fashion.

The investigators evaluated incision enlargement at following points : at the end of phacoemulsification, and then, at the end of IOL implantation The investigators also looked at trypan blue ingress into the anterior chamber from the ocular surface. At 1 day, 1 week, and 1 month after surgery anterior segment OCT morphology was also studied.

further, the surgeon was asked to subjectively grade the ease of implantation with each injector

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autosert Group

Procedure / Surgery : Intraocular lens implantation with Autosert injector

Group Type PLACEBO_COMPARATOR

Intraocular lens implantation

Intervention Type PROCEDURE

Intraocular lens implantation

Autosert Injector

Intervention Type DEVICE

Motorised injection device for intraocular lens implantation

Royale Group

Procedure / Surgery : Intraocular lens implantation with Royale Injector

Group Type PLACEBO_COMPARATOR

Intraocular lens implantation

Intervention Type PROCEDURE

Intraocular lens implantation

Royale Injector

Intervention Type DEVICE

Manual, plunger type injection device for intraocular lens implantation

Monarch III Injector

Procedure / Surgery : Intraocular lens implantation with Monarch III group

Group Type PLACEBO_COMPARATOR

Monarch III Injector

Intervention Type DEVICE

Manual, screw type injection device for intraocular lens implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intraocular lens implantation

Intraocular lens implantation

Intervention Type PROCEDURE

Autosert Injector

Motorised injection device for intraocular lens implantation

Intervention Type DEVICE

Royale Injector

Manual, plunger type injection device for intraocular lens implantation

Intervention Type DEVICE

Monarch III Injector

Manual, screw type injection device for intraocular lens implantation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing phacoemulsification for age-related uncomplicated cataracts through a 2.2mm incision.
* Nuclear or corticonuclear of grade 2 to 4 according to the Lens Opacities Classification System (LOCS III)

Exclusion Criteria

* Glaucoma,
* uveitis,
* shallow anterior chamber (depth \<2.1mm),
* prior ocular trauma or surgery,
* maximal pupillary dilatation \<6mm,
* high myopia (axial length \>25mm),
* posterior polar cataracts,
* dense cataracts, and
* an IOL power \<19.0 D or \>25.0 D
Minimum Eligible Age

40 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iladevi Cataract and IOL Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abhay R. Vasavada

M.S., F.R.C.S (England)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

abhay r vasavada, ms, frcs

Role: PRINCIPAL_INVESTIGATOR

iladevi cataract & iol research centre

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Photopic and Mesopic Multifocal IOL Performance
NCT06978556 ACTIVE_NOT_RECRUITING